Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2018 2
2019 2
2020 3
2021 8
2022 16
2023 12
2024 21
2025 27

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
ADAR1-high tumor-associated macrophages induce drug resistance and are therapeutic targets in colorectal cancer.
Umeda H, Shigeyasu K, Takahashi T, Moriwake K, Kondo Y, Yoshida K, Takeda S, Yano S, Matsumi Y, Kishimoto H, Fuji T, Yasui K, Yamamoto H, Takagi K, Kayano M, Michiue H, Nakamura K, Mori Y, Teraishi F, Tazawa H, Umeda Y, Kagawa S, Goel A, Fujiwara T. Umeda H, et al. Among authors: yasui k. Mol Cancer. 2025 Apr 16;24(1):116. doi: 10.1186/s12943-025-02312-y. Mol Cancer. 2025. PMID: 40241135 Free PMC article.
The state of robotic vs. open pancreatoduodenectomy.
Takagi K, Fuji T, Yasui K, Yamada M, Nishiyama T, Nagai Y, Kanehira N, Fujiwara T. Takagi K, et al. Among authors: yasui k. Gland Surg. 2024 Aug 31;13(8):1344-1348. doi: 10.21037/gs-24-182. Epub 2024 Aug 20. Gland Surg. 2024. PMID: 39282045 Free PMC article. No abstract available.
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.
Hashimoto M, Kuroda S, Kanaya N, Kadowaki D, Yoshida Y, Sakamoto M, Hamada Y, Sugimoto R, Yagi C, Ohtani T, Kumon K, Kakiuchi Y, Yasui K, Kikuchi S, Yoshida R, Tazawa H, Kagawa S, Yagi T, Urata Y, Fujiwara T. Hashimoto M, et al. Among authors: yasui k. Br J Cancer. 2024 Apr;130(7):1187-1195. doi: 10.1038/s41416-024-02583-0. Epub 2024 Feb 5. Br J Cancer. 2024. PMID: 38316993 Free PMC article.
Feasibility of local therapy for recurrent pancreatic cancer.
Sato H, Yoshida R, Yasui K, Umeda Y, Yoshida K, Fuji T, Kumano K, Takagi K, Yagi T, Fujiwara T. Sato H, et al. Among authors: yasui k. Pancreatology. 2022 Sep;22(6):774-781. doi: 10.1016/j.pan.2022.05.004. Epub 2022 May 24. Pancreatology. 2022. PMID: 35641368 Review.
BRAF-mutant microsatellite-stable rectal cancer with acquired KRAS mutation leading to drug resistance in liver metastasis.
Shigeyasu K, Yamamoto H, Takahashi T, Moriwake K, Kayano M, Takeda S, Matsumi Y, Umeda Y, Kondo Y, Teraishi F, Yasui K, Fuji T, Kagawa S, Fujiwara T. Shigeyasu K, et al. Among authors: yasui k. Int Cancer Conf J. 2024 Apr 18;13(3):189-192. doi: 10.1007/s13691-024-00678-2. eCollection 2024 Jul. Int Cancer Conf J. 2024. PMID: 38962037 Free PMC article.
83 results